Effector Therapeutics Inc (EFTR) — Defensive Interval Ratio
Effector Therapeutics Inc (EFTR) has a Defensive Interval Ratio of 141 days as of March 2024. Defensive assets of $9.89 Million (cash $-, short-term investments $9.88 Million, receivables $17.00K) cover 141 days of daily cash needs of $70.05K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Effector Therapeutics Inc Defensive Interval Ratio (2021–2023)
This chart shows how Effector Therapeutics Inc's Defensive Interval Ratio has evolved across 3 annual periods from 2021 to 2023. As of March 2024, the ratio stands at 141 days, meaning defensive assets of $9.89 Million can fund 141 days of operations without new revenue. For the complete balance sheet picture, see EFTR total assets.
Annual Defensive Interval Ratio for Effector Therapeutics Inc (2021–2023)
The table below presents the year-by-year Defensive Interval Ratio for Effector Therapeutics Inc from 2021 to 2023, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See EFTR current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 50 days | $3.55 Million | $70.67K/day | $- | $3.50 Million | ▼ -206 days |
| 2022 | 257 days | $17.63 Million | $68.70K/day | $- | $17.60 Million | ▲ +247 days |
| 2021 | 9 days | $100.00K | $10.90K/day | $- | $0.00 | — |